IP Library › Granted Patent US 9,983,206
Granted Patent B2
US 9,983,206 · App. 14/209,746 · Granted May 29, 2018

Methods and compositions for enhancing immunoassays

Inventors: Ryan C. Bailey (Urbana, IL); Matthew S. Luchansky (Allison Park, PA); Abraham J. Qavi (Champaign, IL); Jared T. Kindt (Champaign, IL)
Assignee: The Board of Trustees of the University of Illinois
G01N33/54373G01N2333/5412G01N2333/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,983,206
App. No.
14/209,746
Granted
May 29, 2018
Kind
B2
Abstract

Embodiments of the methods, compositions, and systems provided herein relate to enzymatic enhancement of immunoassays using photonic sensor arrays.

Claims (16)

1. A method of detecting interleukin-2 (IL-2) comprising:

(a) obtaining a fluidic cell comprising an optical ring resonator having a first anti-cytokine antibody attached thereto, wherein the first anti-cytokine antibody is anti-IL-2 from clone 555051 antibody;

(b) contacting the first anti-cytokine antibody with a sample comprising IL-2 that selectively binds to the anti-cytokine antibody;

(c) contacting the bound IL-2 with a second anti-cytokine antibody that selectively binds to the IL-2, wherein the second anti-cytokine antibody is a biotinylated anti-IL-2 from clone 555040 antibody;

(d) contacting the biotinylated second anti-cytokine antibody with a streptavidin-horseradish peroxidase conjugate;

(e) contacting the horseradish peroxidase with a substantially continuous flow of a solution comprising 4-chloro-1-naphthol and hydrogen peroxide, under conditions that oxidize 4-chloro-1-naphthol to 4-chloro-1-naphthon, whereby the 4-chloro-1-naphthon precipitates on the surface of the optical ring resonator during the substantially continuous flow of the solution; and

(f) measuring a change in resonance wavelengths of the optical ring resonator, thereby indicating the presence of the IL-2.

2. The method of claim 1 , wherein the concentration of hydrogen peroxide is less than about 0.003%.

3. The method of claim 1 , wherein a concentration of the cytokine less than about 100 pg/ml is detected.

4. The method of claim 1 , wherein a continuous flow of reagents contacting the optical ring resonator having a first anti-cytokine antibody attached thereto is maintained for step (b).

5. The method of claim 1 , wherein a substantially continuous flow of reagents contacting the optical ring resonator having a first anti-cytokine antibody attached thereto is maintained for each of steps (b), (c), (d), and (e).

6. The method of claim 1 , wherein a continuous flow of reagents contacting the optical ring resonator having a first anti-cytokine antibody attached thereto is maintained for each of steps (b), (c), (d), and (e).

7. The method of claim 1 , wherein steps (b)-(e) comprise maintaining a flow of reagents contacting the optical ring resonator having a first anti-cytokine antibody attached thereto.

8. The method of claim 7 , wherein the flow rate of the reagents is about 30 μL/min.

9. The method of claim 1 , wherein a continuous flow of the solution is maintained for step (e).

10. The method of claim 9 , wherein the continuous flow of the solution is maintained for steps (e) and (f).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2015
From: BAILEY, RYAN C.; LUCHANSKY, MATTHEW S.; QAVI, ABRAHAM J.; KINDT, JARED T.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 036194/0065 →
Continuity (2)
Provisional Application 61788279 · Mar 15, 2013
Related Publication 20140273029A1 · Sep 18, 2014